patients with myasthenia gravis ( mg ) have increased tolerance to the neuromuscular blocking properties of suxamethonium ( sch ) and decamethonium ( c10 ) and exhibit a reversal of the c10-induced block by neostigmine .
C0026896
myasthenia gravis
C0027679
neostigmine